Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response
From MaRDI portal
Publication:2284788
DOI10.1016/j.amc.2019.124758zbMath1433.35164OpenAlexW2980088238WikidataQ127064337 ScholiaQ127064337MaRDI QIDQ2284788
A. D. Al Agha, Aatef Hobiny, Ahmed M. Elaiw
Publication date: 15 January 2020
Published in: Applied Mathematics and Computation (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.amc.2019.124758
Epidemiology (92D30) Reaction-diffusion equations (35K57) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50) Medical epidemiology (92C60) Initial-boundary value problems for second-order parabolic systems (35K51)
Related Items
Dynamic behaviour and stabilisation to boost the immune system by complex interaction between tumour cells and vitamins intervention ⋮ Stability preserving NSFD scheme for a general virus dynamics model with antibody and cell-mediated responses ⋮ An efficient numerical simulation of a reaction-diffusion malaria infection model using B-splines collocation ⋮ Stability of general pathogen dynamic models with two types of infectious transmission with immune impairment ⋮ Global properties of saturated chikungunya virus dynamics models with cellular infection and delays ⋮ Stability of a discrete-time general delayed viral model with antibody and cell-mediated immune responses ⋮ Global stability of a delayed adaptive immunity viral infection with two routes of infection and multi-stages of infected cells ⋮ GLOBAL PROPERTIES OF HIV DYNAMICS MODELS INCLUDING IMPAIRMENT OF B-CELL FUNCTIONS ⋮ Chemotaxis systems in complex frameworks: Pattern formation, qualitative analysis and blowup prevention ⋮ Stability analysis of a general HIV dynamics model with multi-stages of infected cells and two routes of infection ⋮ Stability of an adaptive immunity delayed HIV infection model with active and silent cell-to-cell spread ⋮ Global dynamics of secondary DENV infection with diffusion ⋮ Global dynamics of SARS-CoV-2/cancer model with immune responses ⋮ Stability of a discrete-time pathogen infection model with adaptive immune response ⋮ Stability of an adaptive immunity viral infection model with multi-stages of infected cells and two routes of infection ⋮ Impact of adaptive immune response and cellular infection on delayed virus dynamics with multi-stages of infected cells ⋮ Global analysis of a reaction–diffusion blood-stage malaria model with immune response ⋮ Analysis of an HTLV/HIV dual infection model with diffusion ⋮ A spectrally accurate time-space pseudospectral method for reaction-diffusion malaria infection model
Cites Work
- Unnamed Item
- Unnamed Item
- A mathematical model verifying potent oncolytic efficacy of M1 virus
- Lytic cycle: A defining process in oncolytic virotherapy
- Analysis of virotherapy in solid tumor invasion
- Global properties of a class of HIV models
- Mathematical analysis of a basic virus infection model with application to HBV infection
- Introduction to functional differential equations
- Global properties of delayed-HIV dynamics models with differential drug efficacy in cocirculating target cells
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
- The replicability of oncolytic virus: defining conditions in tumor virotherapy
- Hopf bifurcation analysis and optimal control of treatment in a delayed oncolytic virus dynamics
- Enhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysis
- Dynamic analysis and optimal control for a model of hepatitis C with treatment
- Stabilization in a chemotaxis model for virus infection
- Dynamics of a diffusive virus model with general incidence function, cell-to-cell transmission and time delay
- Threshold dynamics of HCV model with cell-to-cell transmission and a non-cytolytic cure in the presence of humoral immunity
- Dynamics of a diffusive HBV model with delayed Beddington-DeAngelis response
- Dynamical behavior of a new oncolytic virotherapy model based on gene variation
- Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?
- The competitive dynamics between tumor cells, a replication-competent virus and an immune response
- Stability of an adaptive immunity pathogen dynamics model with latency and multiple delays
- Stability of a CD4+ T cell viral infection model with diffusion
- Diffusion-driven instability in reaction-diffusion systems
